行情

SIGA

SIGA

SIGA Tech
NASDAQ

实时行情|Nasdaq Last Sale

5.70
+0.04
+0.71%
盘后: 5.70 0 0.00% 16:00 09/13 EDT
开盘
5.68
昨收
5.66
最高
5.80
最低
5.63
成交量
14.67万
成交额
--
52周最高
8.09
52周最低
4.680
市值
4.62亿
市盈率(TTM)
1.067
分时
5日
1月
3月
1年
5年

SIGA 新闻

  • 新华国际时评:央行“放水”恐难纾欧元区之困
  • 新华网.2小时前
  • 沙特官员:周一石油产量将恢复到正常水平
  • 新浪美股.3小时前
  • 丰田向松下采购5万套特斯拉“同款”电池销售到中国
  • TechWeb.3小时前
  • 为了冲刺第三季度业绩,特斯拉展开了“花式促销”
  • 界面.4小时前

更多

所属板块

生物技术和医学研究
+0.20%
制药与医学研究
-0.38%

热门股票

名称
价格
涨跌幅

SIGA 简况

SIGA Technologies, Inc. is engaged in the development and commercialization of solutions for various unmet medical needs and biothreats. The Company's lead product is TPOXX, an orally administered antiviral drug that targets orthopoxviruses infections. TPOXX is a small-molecule drug delivered to the Strategic Stockpile under the Project BioShield Act of 2004 (Project BioShield). TPOXX is an investigational product that is not approved by the United States Food and Drug Administration (FDA) as a treatment of smallpox or any other indication. The Company relies on and uses third parties known as contract manufacturing organizations (CMOs) to procure commercial raw materials and supplies, and to manufacture TPOXX. The Company identified a lead pre-clinical drug candidate with activity against four serotypes of the virus and which has shown efficacy in a murine model of disease.
展开

Webull提供SIGA Technologies, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。